Poster Guidelines

Poster Guidelines

Poster Guidelines

 Paper presentations can be divided into two categories:

a) Scientific Research Poster (SRP)

b) Narrative or Systematic Review Poster (SRP)

 

Abstract Guidelines

  • The official language is English. This should be used in the preparation of posters.
  • All submitted and approved abstracts must be presented as a poster, even if they have been selected for flash poster presentations.

 

  • Registration online WITH abstract until  08/22/2025 .
  • All abstracts must be submitted via mail (riicep.ufsj@gmail.com).
  • Abstracts will only be evaluated after payment of the registration fee.
  • Title: Times New Roman, 12 points, Upper case, Centered text in bold (Follow the template).
  • Body: Times New Roman, 11 points; Line spacing: 1, one column of text (Follow the template).
  • It should be one paragraph with a word limit of:
    •  300 for Poster de Pesquisa Científica (PPC)
    • 500 for Narrative or Systematic Reviews (PRS) Poster
  • The abstract should be submitted in word format (.doc or .docx) document.
  • Acronyms should be written in full the first time, mentioned in the text, and followed by the abbreviation in parentheses.
  • Final result September 15th.

 

Abstract sessions

  • Pre-Clinical assays
  • Novel Developments in Drug Delivery System
  • Plant Based Nutrition
  • Natural sources of cosmetic active ingredients
  • Pharmaceutical Biotechnology
  • Safety and regulatory aspects of herbal drugs and Products
  • Phytochemistry
  • Metabolomics of medicinal plants
  • Experimental Pharmacology
  • Phytopharmaceutical Technology
  • Extraction and purification methods of natural products
  • Bioinformatics applied to natural products

 

Note

The assessment of the posters will be based on the content, presentation, and ability to communicate the research output to the assessor(s) and other participants.

 

Poster Guidelines

  • Posters will be displayed in portrait format.
  • The dimensions of the poster should be 84,1 cm x 118,9 cm (in A0 format).
  • Abstract title, author(s) and affiliation(s) should appear at the top of the poster.
  • The presence of the Congress logo on the poster is mandatory.
  • Should the presenter not be in his position, the Poster will not be evaluated.
  • We do not provide a template for your poster.
  • We do not provide printing services.
  •  

Oral presentations Guidelines

  • The dimensions of the PowerPoint should be 16:9.
  • The presence of the Congress logo on presentation (Canva, PPT, PDF) is mandatory.
  • We do not provide a template for your oral presentations.
  • Authors must present their abstract for 10 minutes and then have 5 minutes to answer the examiners' questions.

  

After completing registration and payment, please send your abstracts to the following email address: riicep.ufsj@gmail.com

 

Each registration allows the same presenter to submit up to two abstracts.

 

Choose one of the options:

_____Poster presentation

_____Oral presentation

 

____ Scientific Research Poster (SRP)

____ Narrative or Systematic Review Poster (SRP)

 

Model

IDENTIFICATION, SYNTHESIS AND EVALUATION OF THE PHARMACOLOGICAL OF THE PEPTIDE ISOLATED FROM THE VENOM OF THE SPIDER LYCOSA ERYTHROGNATHA: IN SILICO AND IN VITRO STUDY

Paulo Silva1*, João Souza2

1 Laboratory….., University or Research institution, Country; 2 Laboratory…….., University or Research institution, Country

*corresponding author’s email: xxxx@gmail.com

 

Introduction: Spider venom is a cocktail of compounds such as salts, peptides, proteins, and other components. Among them, peptides have different pharmacological properties, such as antitumor and antimicrobial activity, making them promising candidates for the development of new drugs. Objectives: Identity, synthesize and purify the Ly peptide isolated from the venom of the spider Lycosa erythrognatha and evaluate its antitumor and antimicrobial activity. Methodology: Initially, the extraction of the venom of the spider Lycosa erythrognatha was carried out and for its purification and identification of the peptides, HPLC and mass spectrometry were used. After identifying the sequences, in silico analyses of structure prediction and molecular modeling were performed. Then, the Ly peptide was selected and synthesized (Fmoc/t-butyl strategy). MTT assay with a glioblastoma cell line (U87) and a normal astrocyte cell line (NHA) was used to evaluate the cytotoxic and selectivity of the peptide. The antimicrobial activity was evaluated with bacteria (Staphylococcus aureus and Escherichia coli) and yeasts (Candida albicans and Candida glabrata), using the minimum inhibitory concentration, fungicide and minimum bactericidal concentration assays. Results: The Ly peptide was successfully synthesized and showed characteristics such as positive charge, helical conformation, and amphipathic structure in silico analyses. Furthermore, the peptide showed antibacterial activity for the gram-negative bacteria E. coli at 64 µg/ml but did not demonstrate antimicrobial activity for S. aureus, C. albicans and C. glabrata. The peptide was not cytotoxic to the glioblastoma cell line or the normal cell line. Conclusions: The Ly peptide showed antimicrobial activity. The results show the potential to new investigate its activity in different types of tumor cell lines and toxicity studies in other microorganisms.

 

  • Key Words: Molecular modeling, antitumor, antimicrobial, venom.
  • Acknowledgements: This research was supported by CAPES and CNPq.
  • Abstract session: Extraction and purification methods of natural products.